Several leading medical organizations have released updated recommendations for flu, COVID-19, and respiratory syncytial virus (RSV) vaccines for the 2026-27 respiratory season. The guidance, available through the Vaccine Integrity Project, is especially important for people with myasthenia gravis (MG), because some MG treatments can weaken immune defenses.

Myasthenia gravis is an autoimmune disease that causes muscle weakness and fatigue. Infections can worsen MG symptoms in some people, and some treatments used for MG suppress the immune system.

Vaccination is one way to help prevent infections that could trigger or worsen symptoms. Vaccines train the immune system to recognize and fight specific viruses. As a result, your body can respond more quickly if you’re exposed to them.

🗳️ Have you spoken with your doctor about COVID-19, flu, or RSV vaccinations for 2026-2027?

Yes, and it was helpful

Yes, but it wasn’t helpful

No, but I plan to

No, and I don’t plan to

Thanks! You've successfully submitted your vote.

Sign up to view the results!

Continue with Facebook

Continue with Google

Continue with Email

By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.

Already a member? Log In

There isn’t one vaccine plan that’s right for everyone with myasthenia gravis. Your age, treatment plan, immune function, vaccination history, and other health conditions can all influence which vaccines are recommended and when you should receive them.

The Vaccine Integrity Project, working with the American Medical Association, reviewed the latest evidence on flu, COVID-19, and RSV immunizations for the 2026-27 respiratory season. The findings helped inform recommendations from several leading medical organizations, including:

The review included 299 studies published mostly between August 2025 and June 2026. It found that flu, COVID-19, and RSV immunizations continued to provide meaningful protection against hospitalization, severe illness, and death.

The amount of protection can vary based on the virus, the vaccine or immunization, the season, and a person’s health. For people with myasthenia gravis, vaccination decisions should take into account factors such as age, treatment, and immune function.

For the 2026-27 respiratory season, COVID-19 and flu vaccines have updated formulations. There are also three RSV vaccines for adults. These vaccines differ in how they are made and which age groups or risk groups they are approved for.

COVID-19 Vaccines

The U.S. Food and Drug Administration (FDA) has approved four COVID-19 vaccine options. All four vaccines are given by injection.

Flu Vaccines

All U.S. flu vaccines for the 2026-27 season are trivalent, meaning they are designed to protect against three influenza viruses.

Most people need one flu vaccine dose each season. Some children may need a second dose based on their age, vaccination history, or individual health circumstances. For people with MG who take medicines that weaken the immune system, vaccine type or timing may need to be coordinated with treatment.

RSV Vaccines

There are three FDA-approved adult RSV vaccines.

For adults, the CDC recommends a single dose of RSV vaccine for everyone age 75 and older and for adults ages 50 through 74 who are at increased risk of severe RSV illness. For people with weakened immune systems, the IDSA recommends RSV vaccination starting at age 18.

Some MG treatments can weaken immune defenses, so your healthcare team can help determine whether this guidance applies to you. The RSV vaccine isn’t currently given every year.

For people who are immunocompromised, the benefits of vaccination generally outweigh the risks. Current evidence shows that flu, COVID-19, and RSV immunizations can reduce hospitalization, severe illness, and death. People with weakened immune systems may not respond as strongly to vaccines, but vaccination can still provide protection.

Vaccines can cause side effects, but serious side effects are uncommon. Your healthcare team can explain what to expect and help you weigh the benefits and risks based on your:

The right vaccine and timing can vary for people with MG. Some MG treatments suppress the immune system, which can affect which vaccines are appropriate or how strongly your body responds to them.

Ask not only which products are available, but which type, dose, and timing make sense for you.

Your healthcare team may consider:

Some vaccine types may not be appropriate for people taking certain MG treatments. For example, the nasal spray flu vaccine is a live vaccine and is generally avoided in people taking immunosuppressive medications. The Myasthenia Gravis Foundation of America recommends discussing vaccine type with your doctor if you take an immunosuppressive drug.

Timing Around Treatments

Timing may also matter, particularly for people taking medications that suppress the immune system. Vaccines may not produce as strong an immune response during some immunosuppressive treatments.

Your healthcare team can recommend the best timing based on your MG treatment and immune function. Don’t delay, skip, or change MG treatment to get vaccinated unless your healthcare team recommends it.

Some MG treatments that weaken the immune system can reduce the body’s response to vaccines. That doesn’t mean vaccination has no benefit.

The Vaccine Integrity Project found that respiratory virus immunizations continued to reduce severe outcomes among people with immunocompromising conditions, although protection varied.

In many cases, COVID-19, flu, and RSV vaccines can be given at the same visit.

Whether that makes sense for you may depend on your MG treatment schedule, previous vaccinations, expected side effects, and other health needs. Ask your healthcare team whether getting more than one vaccine at the same appointment is appropriate.

7 Questions To Ask Your Healthcare Team About Seasonal Vaccines